Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Conditions News
Tennessee E. coli outbreak linked to raw milk from multistate cow-share
An outbreak of Shiga toxin-producing Escherichia coli in Tennessee was caused by raw milk consumption among members of a cow-share, according to a study.
Multidrug-resistant bacteria prevalent in supermarket meat, study finds
Researchers in Spain reported that nearly half of supermarket meat samples tested in a study contained multidrug-resistant or potentially pathogenic Escherichia coli.
Log in or Sign up for Free to view tailored content for your specialty!
Fecal transplants for babies born by cesarean section may contain harmful pathogens
More than 40% of healthy mothers recruited for a study testing fecal transplantation for babies born by cesarean section tested positive for potentially harmful pathogens, Finnish researchers reported.
Gut microbiome dysbiosis associated with ADHD
The gut microbiomes of children with ADHD differed from those of children without ADHD, findings published in The Journal of Child Psychology and Psychiatry showed.
Adenovirus re-emerges as likely culprit in 2022 outbreak of acute hepatitis in children
A 2022 outbreak of unexplained acute severe hepatitis in children has been linked to a strain of adeno-associated virus 2, supporting the theory that disease pathogenesis results from viral coinfection, according to data reported in Nature.
Q&A: In utero exposure to Bendectin linked to increased risk for CRC in adult offspring
Prenatal exposure in the 1960s and ’70s to dicyclomine, a component of the anti-nausea drug Bendectin, increased the risk for colorectal cancer in adult offspring, according to data reported in JNCI Cancer Spectrum.
Mystery hepatitis culprit still unidentified: Timeline of a global outbreak in children
Since April 2022, more than 1,300 children in 35 countries have developed acute severe hepatitis of unknown etiology, with the United States and the United Kingdom accounting for 65% of global cases, according to recent WHO data.
FDA agrees on Abivax’s pediatric study plan to develop obefazimod for children with IBD
The FDA has agreed on Abivax’s initial pediatric study plan for the development of obefazimod in children aged 2 to 17 years with inflammatory bowel disease, the company announced in a press release.
Treatment for pediatric gut-brain interaction disorders relies on caring for the whole child
Disorders of gut-brain interaction cause symptoms throughout the digestive tract including pain, changes in bowel patterns, nausea, regurgitation or vomiting, which can be upsetting or embarrassing for children and teens
Ustekinumab, vedolizumab ‘seem perfectly safe’ during pregnancy in IBD patients
CHARLOTTE, N.C. — Exposure to ustekinumab and vedolizumab during pregnancy did not increase maternal and fetal complications, and researchers recommend continued use in pregnant mothers with inflammatory bowel disease.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read